HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

TRAK

ReposiTrak, Inc. (NYSE)

Technology — Software - Application

ReposiTrak, Inc., a software-as-a-service provider, operates a business-to-business, e-commerce, compliance and traceability, and supply chain management platform in North America. It offers ReposiTrak Compliance Management, which reduces potential regulatory, legal, and criminal risks from its supply chain partners; ReposiTrak Traceability Network, which captures key data elements for designated products; and ReposiTrak Supply Chain Solutions, which enable customers to manage interactions with suppliers. The company also provides business consulting services to suppliers and retailers in the grocery, convenience, and specialty retail sectors. In addition, it provides professional consulting services. The company primarily serves multi-store retail chains, wholesalers, distributors, and their suppliers. ReposiTrak, Inc. has a strategic partnership with Upshop to enable grocery retail traceability. The company was formerly known as Park City Group, Inc. and changed its name to ReposiTrak, Inc. in December 2023. ReposiTrak, Inc. is based in Murray, Utah.

None 1 analysts
$8.10
$-0.31 (-3.75%)
Target: $16.00 (97.5%)
Sign in to add TRAK to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$175.74M
P/E Ratio (TTM)26.14
Forward P/E24.79
EPS (TTM)$0.37
Dividend Yield0.84%
Profit Margin31.05%
Revenue Growth-0.50%
ROE14.66%
Debt/Equity0.69
Recommendation None
Analyst Target$16.00
Analysts1
Indexes NYSE

Technical Indicators

RSI (14)49.4
Beta0.80
SMA 20-
SMA 40-
52-Week High$20.15
52-Week Low$6.94
50-Day Avg$9.53
200-Day Avg$11.38
Avg Volume115.7K
Volume40.4K

Performance Analysis

NEUTRAL

TRAK presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($6.94), which could present a value opportunity.
~ RSI at 49.4 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 0.5% year-over-year.
+ Healthy profit margin of 31.0%.
~ Wall Street consensus is "none" from 1 analysts.
+ Average analyst target of $16.00 implies 97.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:34 UTC

Back to Screener Export Report